Skip to main content
OpenTrials

Clinical trial condition

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Explore clinical trials studying Precursor Cell Lymphoblastic Leukemia-Lymphoma. Study availability and eligibility vary by location and protocol.

20 public trials 8 recruiting studies
Refine in advanced search Browse all conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma trial results

Completed

A Study to Evaluate the Efficacy and Safety of Daratumumab in Pediatric and Young Adult Participants Greater Than or Equal to (>=)1 and Less Than or Equal to (<=) 30 Years of Age With Relapsed/Refractory Precursor B-cell or T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

NCT03384654

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • UCSF Benioff Children's Hospital Oakland Oakland, California, United States
  • Children's Hospital Orange County Orange, California, United States
View all 53 locations
View Trial Details
Completed

InO - A Retrospective Study of UK Patients With Leukaemia

NCT04456959

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations
  • University Hospitals Bristol NHS Foundation Trust Bristol, United Kingdom
  • University College London Hospital NHS Foundation Trust London, United Kingdom
  • The Royal Marsden NHS Foundation Trust of Fulham Road London, United Kingdom
  • Taunton and Somerset NHS Foundation Trust of Musgrove Park Hospital Taunton, United Kingdom
View Trial Details
Completed

Childhood Acute Lymphoblastic Leukaemia: Follow-Up

NCT03545659

Conditions
Disease Attributes, Hematologic Diseases, Hemic and Lymphatic Diseases, +12 more
Locations
  • Department of Paediatrics and Adolescent Medicine, Aarhus University Hospital Aarhus N, Denmark
  • Department of Paediatrics and Adolescent Medicine, Turku University Hospital Turku, Finland
  • The National University Hospital of Iceland Reykjavik, Iceland
  • Department of Childhood Oncology, University Hospital Tromsø Tromsø, Norway
View Trial Details

Related conditions